Pathophysiology of pulmonary nontuberculous mycobacterial (NTM) disease

被引:10
|
作者
Matsuyama, Masashi [1 ,2 ]
Matsumura, Sosuke [1 ]
Nonaka, Mizu [1 ]
Nakajima, Masayuki [1 ]
Sakai, Chio [1 ]
Arai, Naoki [1 ]
Ueda, Kodai [1 ]
Hizawa, Nobuyuki [1 ]
机构
[1] Univ Tsukuba, Inst Med, Dept Resp Med, Tsukuba, Japan
[2] Univ Tsukuba, Inst Med, Dept Pulm Med, 1-1-1 Tennoudai, Ibaraki, Tsukuba 3058575, Japan
关键词
Nontuberculous mycobacteria (NTM); Soil; Shower head; IFN-g; IL-12; axis; Mucociliary clearance; TUMOR-NECROSIS-FACTOR; AVIUM COMPLEX; LUNG-DISEASE; IN-VITRO; GAMMA AUTOANTIBODIES; BEAT FREQUENCY; INFECTION; SUSCEPTIBILITY; PREVALENCE; IMMUNODEFICIENCY;
D O I
10.1016/j.resinv.2022.12.002
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
In recent years, the incidence and prevalence of pulmonary nontuberculous mycobacterial (NTM) disease have increased worldwide. Although the reasons for this increase are un-clear, dealing with this disease is essential. Pulmonary NTM disease is a chronic pulmonary infection caused by NTM bacteria, which are ubiquitous in various environments. In Japan, Mycobacterium avium-intracellulare complex (MAC) accounts for approximately 90% of the causative organisms of pulmonary NTM disease, which is also called pulmonary MAC disease or pulmonary MAI disease.It is important to elucidate the pathophysiology of this disease, which occurs frequently in postmenopausal women despite the absence of obvious immunodeficiency. The path-ophysiology of this disease has not been fully elucidated; however, it can largely be divided into bacterial (environmental) and host-side problems. The host factors can be further divided into immune and airway problems. The authors suggest that the triangular rela-tionship between bacteria, immunity, and the airway is important in the pathophysiology of this disease. The latest findings on the pathophysiology of pulmonary NTM disease are reviewed.(c) 2022 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:135 / 148
页数:14
相关论文
共 50 条
  • [1] Management of Nontuberculous Mycobacterial (NTM) Lung Disease
    Philley, Julie V.
    Griffith, David E.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (01) : 135 - 142
  • [2] Risk factors for nontuberculous mycobacterial pulmonary disease (NTM-PD) in Croatia
    Goran Glodić
    Miroslav Samaržija
    Ivan Sabol
    Ljiljana Bulat Kardum
    Vesna Carević Vladić
    Feđa Džubur
    Marko Jakopović
    Ivana Kuhtić
    Ante Marušić
    Dina Mihelčić
    Sanja Popović Grle
    Dražen Strelec
    Tomislav Šklebar
    Ana Marija Šola
    Ljiljana Žmak
    Jakko van Ingen
    Mateja Janković Makek
    Wiener klinische Wochenschrift, 2021, 133 : 1195 - 1200
  • [3] Risk factors for nontuberculous mycobacterial pulmonary disease (NTM-PD) in Croatia
    Glodic, Goran
    Samarzija, Miroslav
    Sabol, Ivan
    Kardum, Ljiljana Bulat
    Vladic, Vesna Carevic
    Dzubur, Feda
    Jakopovic, Marko
    Kuhtic, Ivana
    Marusic, Ante
    Mihelcic, Dina
    Grle, Sanja Popovic
    Strelec, Drazen
    Sklebar, Tomislav
    Sola, Ana Marija
    Zmak, Ljiljana
    van Ingen, Jakko
    Makek, Mateja Jankovic
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (21-22) : 1195 - 1200
  • [4] Nontuberculous Mycobacterial (NTM) Disease Among Pulmonary Tuberculosis Suspects in India: A Multicentre Study
    Sharma, S. K.
    Upadhyay, V.
    Solanki, R.
    Patel, P.
    Patel, M.
    Dewan, R. K.
    Verma, A. K.
    Ranjan, A.
    Yadav, R. N.
    Hanif, M.
    Chopra, K. K.
    Dwivedi, K. K.
    Mohan, A.
    Jayaprada, R.
    Ghewade, B.
    Bhanushali, J.
    Hasnain, S. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [5] Nontuberculous mycobacterial pulmonary disease
    Johnson, Margaret M.
    Waller, Ernest Andrew
    Leventhal, Jack P.
    CURRENT OPINION IN PULMONARY MEDICINE, 2008, 14 (03) : 203 - 210
  • [6] Nontuberculous mycobacterial (NTM) lung disease: The top ten essentials
    Aksamit, Timothy R.
    Philley, Julie V.
    Griffith, David E.
    RESPIRATORY MEDICINE, 2014, 108 (03) : 417 - 425
  • [7] Nontuberculous mycobacterial pulmonary disease
    Ringshausen, F. C.
    Rademacher, J.
    INTERNIST, 2016, 57 (02): : 142 - 151
  • [8] Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement
    van Ingen, Jakko
    Aksamit, Timothy
    Andrejak, Claire
    Bottger, Erik C.
    Cambau, Emmanuelle
    Daley, Charles L.
    Griffith, David E.
    Guglielmetti, Lorenzo
    Holland, Steven M.
    Huitt, Gwen A.
    Koh, Won-Jung
    Lange, Christoph
    Leitman, Philip
    Marras, Theodore K.
    Morimoto, Kozo
    Olivier, Kenneth N.
    Santin, Miguel
    Stout, Jason E.
    Thomson, Rachel
    Tortoli, Enrico
    Wallace, Richard J., Jr.
    Winthrop, Kevin L.
    Wagner, Dirk
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (03)
  • [9] Nontuberculous mycobacterial pulmonary disease (NTM PD) incidence trends in the United States, 2010-2019
    Bents, Samantha J.
    Mercaldo, Rachel A.
    Powell, Collin
    Henkle, Emily
    Marras, Theodore K.
    Prevots, D. Rebecca
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [10] Characteristics associated with initiation of treatment for nontuberculous mycobacterial (NTM) pulmonary disease in the non-HIV population
    Tatem, G
    Jaffery, H
    Digiovine, B
    Betensley, AD
    CHEST, 2003, 124 (04) : 96S - 97S